Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?

J Hypertens. 2019 May;37(5):902-904. doi: 10.1097/HJH.0000000000002018.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents*
  • Blood Pressure / drug effects
  • Blood Pressure Determination*

Substances

  • Antihypertensive Agents